|
EMA Publishes Nine PARs for Ancillary Drugs Included in Medical Devices
In an effort at greater transparency, the European Medicines Agency (EMA) has begun publishing public assessment reports (PAR) for ancillary drug substances incorporated in medical devices.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives